—
Overview for Global Vocal Biomarkers MarketThe Vocal Biomarkers Market is chiefly driven by rise in cases of psychological, neurological and other diseases affecting speech such as depression, Attention Deficit and Disruptive Behavior Disorders, Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, Respiratory and Cardiovascular Disorders, traumatic brain injury (TBI) etc.
According to WHO estimates, around 350 million individuals were suffering from depression in 2016 while the Parkinson’s disease Foundation, estimated about 10 million individuals Parkinson’s patients globally in 2016.
Major Players for Global Vocal Biomarkers Market
Beyond Verbal
Sonde Health
Audio Profiling
IBM Corporation
Cogito Corporation
Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Vocal biomarkers Market” Research Report – Forecast to 2023.
For Exclusive Sample Copy Visit @ https://www.marketresearchfuture.com/sample_request/3933
Growth and Analysis for Global Vocal Biomarkers Market
The increasing penetration of mobile technology and information technology is driving the market. The development of wearable’s coupled with the rising quality and bandwidth availability is another boon for the market for vocal biomarkers.
Product development is an important strategy and the increasing collaboration between technology companies and research institutes will yield multiple benefits to both partners.
For example, Sonde Health Inc., has developed a voice-based technology platform for monitoring and diagnosing diseases and conditions, has collaborated and licensed the technology from the Massachusetts Institute of Technology (MIT).
Another company Beyond Verbal has developed vocal biomarker application for detecting emotions. The emotional analysis uses voice biomarkers to detect the moods such as arousal, temper etc.
For Detailed Reading Visit @ https://www.marketresearchfuture.com/reports/vocal-biomarkers-market-3933
Beyond Verbal has also pursued the partnership strategy with Mayo Clinic, Tel Aviv University and others for the development of vocal biomarkers.
Segmentation for Global Vocal Biomarkers Market
The global vocal biomarkers market is segmented on the basis of type, indications and end users. Based on type the market has been segmented as frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch and others.
Based on the indications, the market has been segmented as psychiatric disorders (depression, attention deficit and disruptive behavior disorders, others), neurological disorders (Parkinson’s disease (PD), Alzheimer's disease, Huntington's disease, others), respiratory disorders, cardiovascular disorders, traumatic brain injury (TBI), others) and others.
Based on end users, the market has been segmented as hospitals and clinics, academic and research and others.
For Exclusive Discount Visit @ https://www.marketresearchfuture.com/check-discount/3933
Some Points form Table of Content of Global Vocal Biomarkers Market
1. Introduction
1.1 Definition
1.2 Scope of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
..TOC Continued
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/rheumatoid-arthritis-market-1658
Release ID: 410396